{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:46:00Z","timestamp":1762980360263,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jiac.2016.12.016","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T04:01:23Z","timestamp":1486008083000},"page":"234-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae strains isolated in Japan after introduction of the routine immunization program"],"prefix":"10.1016","volume":"23","author":[{"given":"Haruko","family":"Miyazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Midorikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2016.12.016_bib1","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O'Brien","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2016.12.016_bib2","doi-asserted-by":"crossref","first-page":"e0131494","DOI":"10.1371\/journal.pone.0131494","article-title":"Effects of infant pneumococcal conjugate vaccination on serotype distribution in invasive pneumococcal disease among children and adults in Germany","volume":"10","author":"van der Linden","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2016.12.016_bib3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2016.12.016_bib4","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3201\/eid1907.121830","article-title":"Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999\u20132011(1.)","volume":"19","author":"Richter","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2016.12.016_bib5","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/cid\/ciu524","article-title":"Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality","volume":"59","author":"Harboe","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2016.12.016_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2016.12.016_bib7","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1016\/j.vaccine.2015.07.069","article-title":"Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: effects of the seven-valent pneumococcal conjugate vaccine","volume":"33","author":"Suga","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2016.12.016_bib8","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3201\/eid2111.142029","article-title":"Serotype changes and drug resistance in invasive pneumococcal diseases in adults after vaccinations in children, Japan, 2010\u20132013","volume":"21","author":"Ubukata","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2016.12.016_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1128\/JCM.44.1.124-131.2006","article-title":"Sequential multiplex pcr approach for determining capsular serotypes of Streptococcus pneumoniae isolates","volume":"44","author":"Pai","year":"2006","journal-title":"J\u00a0Clin Microbiol"},{"year":"2008","series-title":"Performance standards for antimicrobial susceptibility testing; 18th informational supplement","author":"CLSI","key":"10.1016\/j.jiac.2016.12.016_bib10"},{"key":"10.1016\/j.jiac.2016.12.016_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1017\/S0950268809990239","article-title":"Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan","volume":"138","author":"Chiba","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jiac.2016.12.016_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vaccine.2015.11.015","volume":"34","author":"Nakano","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2016.12.016_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1542\/peds.2008-1702","article-title":"Serotype 19a is the most common serotype causing invasive pneumococcal infections in children","volume":"125","author":"Kaplan","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.jiac.2016.12.016_bib14","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3201\/eid1609.100102","article-title":"Pneumococcal serotypes in children in 4 european countries","volume":"16","author":"Hanquet","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2016.12.016_bib15","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1128\/CVI.00381-13","article-title":"Invasive and noninvasive Streptococcus pneumoniae capsule and surface protein diversity following the use of a conjugate vaccine","volume":"20","author":"Croney","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jiac.2016.12.016_bib16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis","volume":"360","author":"Hsu","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jiac.2016.12.016_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/INF.0b013e318275614b","article-title":"Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine","volume":"32","author":"Kaplan","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2016.12.016_bib18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2016.12.016_bib19","doi-asserted-by":"crossref","first-page":"5607","DOI":"10.1016\/j.vaccine.2014.07.108","article-title":"Protective properties of a fusion pneumococcal surface protein a (PspA) vaccine against pneumococcal challenge by five different pspa clades in mice","volume":"32","author":"Piao","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2016.12.016_bib20","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/infdis\/jit502","article-title":"Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-cbpa peptide recombinant fusion protein","volume":"209","author":"Mann","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jiac.2016.12.016_bib21","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1016\/j.vaccine.2012.10.076","article-title":"Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein a (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein d vaccine","volume":"30","author":"Bologa","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2016.12.016_bib22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2012.11.005","article-title":"Safety and immunogenicity of the pneumococcal pneumolysin derivative plyd1 in a single-antigen protein vaccine candidate in adults","volume":"31","author":"Kamtchoua","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2016.12.016_bib23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.vaccine.2013.10.052","article-title":"Adjuvant system as02v enhances humoral and cellular immune responses to pneumococcal protein phtd vaccine in healthy young and older adults: randomised, controlled trials","volume":"33","author":"Leroux-Roels","year":"2015","journal-title":"Vaccine"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17300089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17300089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:55:49Z","timestamp":1761159349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X17300089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1341321X17300089"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2016.12.016","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae strains isolated in Japan after introduction of the routine immunization program","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2016.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}